Hsbc Holdings PLC decreased its position in Nu Skin Enterprises, Inc. (NYSE:NUS) by 30.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 70,103 shares of the company’s stock after selling 31,353 shares during the quarter. Hsbc Holdings PLC owned 0.13% of Nu Skin Enterprises worth $5,778,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also recently added to or reduced their stakes in NUS. OppenheimerFunds Inc. lifted its position in Nu Skin Enterprises by 80.5% in the second quarter. OppenheimerFunds Inc. now owns 267,285 shares of the company’s stock valued at $20,899,000 after purchasing an additional 119,244 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its position in Nu Skin Enterprises by 16.3% in the second quarter. Oregon Public Employees Retirement Fund now owns 21,674 shares of the company’s stock valued at $1,695,000 after purchasing an additional 3,038 shares during the last quarter. ING Groep NV lifted its position in Nu Skin Enterprises by 12.9% in the second quarter. ING Groep NV now owns 8,518 shares of the company’s stock valued at $666,000 after purchasing an additional 976 shares during the last quarter. RBO & Co. LLC bought a new stake in Nu Skin Enterprises in the second quarter valued at approximately $227,000. Finally, Barings LLC lifted its position in Nu Skin Enterprises by 342.8% in the second quarter. Barings LLC now owns 24,930 shares of the company’s stock valued at $1,949,000 after purchasing an additional 19,300 shares during the last quarter. Institutional investors own 74.66% of the company’s stock.
Shares of NUS stock opened at $63.78 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.93 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises, Inc. has a fifty-two week low of $60.60 and a fifty-two week high of $88.68. The company has a market capitalization of $3.54 billion, a price-to-earnings ratio of 16.53, a P/E/G ratio of 1.62 and a beta of 0.99.
Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Wednesday, November 7th. The company reported $0.94 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.96 by ($0.02). Nu Skin Enterprises had a net margin of 5.93% and a return on equity of 27.50%. The business had revenue of $675.31 million for the quarter, compared to analysts’ expectations of $664.99 million. During the same period last year, the firm posted $0.76 earnings per share. Nu Skin Enterprises’s quarterly revenue was up 19.8% on a year-over-year basis. On average, equities analysts predict that Nu Skin Enterprises, Inc. will post 3.51 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Friday, November 30th will be paid a dividend of $0.365 per share. The ex-dividend date is Thursday, November 29th. This represents a $1.46 annualized dividend and a dividend yield of 2.29%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 45.20%.
In other news, General Counsel D Matthew Dorny sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $82.18, for a total transaction of $205,450.00. Following the transaction, the general counsel now directly owns 33,871 shares of the company’s stock, valued at $2,783,518.78. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders have sold 7,500 shares of company stock worth $537,625 over the last three months. Insiders own 5.20% of the company’s stock.
Several brokerages have weighed in on NUS. Jefferies Financial Group reiterated a “buy” rating and issued a $98.00 price objective on shares of Nu Skin Enterprises in a research report on Tuesday, September 4th. Zacks Investment Research downgraded Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Tuesday, October 23rd. Tigress Financial reiterated a “buy” rating on shares of Nu Skin Enterprises in a research report on Wednesday, November 21st. Citigroup set a $88.00 price objective on Nu Skin Enterprises and gave the company a “buy” rating in a research report on Thursday, November 8th. Finally, Bank of America reiterated an “underperform” rating and issued a $65.00 price objective (down previously from $75.00) on shares of Nu Skin Enterprises in a research report on Thursday. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $83.63.
COPYRIGHT VIOLATION NOTICE: “Hsbc Holdings PLC Sells 31,353 Shares of Nu Skin Enterprises, Inc. (NUS)” was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.americanbankingnews.com/2018/12/08/hsbc-holdings-plc-sells-31353-shares-of-nu-skin-enterprises-inc-nus.html.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Further Reading: Candlestick
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.